This site is only for use by healthcare professionals. By continuing to view this site you are confirming that you are a healthcare professional.
The urea cycle is a biochemical pathway consisting of six enzymes and two mitochondrial transporters responsible for the elimination of excess nitrogen arising from the breakdown of protein and other...
Associate Professor Simone Strasser University of Sydney, New South Wales, Australia COVID-19 effects in patients with liver disease Up to 40% of individuals who acquire...
Akne-Narben treten häufig als Folge der chronischen Entzündungen auf und können mit körperdysmorphen Störungen verbunden sein.1 Neben physikalischen oder chemischen Maßnahmen haben sich in der...
Over the past few years, the IL-23 pathway has emerged as a promising target for therapeutic intervention in a range of diseases. This symposium held at EADV 2020 looked at the latest discoveries on...
The IL-23 pathway has emerged as a promising target in the management of psoriatic diseases. This symposium held at EADV 2020 aimed to give an update on the latest developments from both...
The COVID-19 pandemic has transformed healthcare delivery worldwide. Healthcare professionals working in hospitals and private practices are increasingly turning to telemedicine as a way to safely...
Crohn’s disease (CD) is a chronic, relapsing immune system dysfunction that has a significant impact on quality of life. Despite advances in our understanding of the disease pathogenesis in recent...
Adult Immunization in India is a reference book by the esteemed members of the Association of Physicians of India to create awareness among healthcare professionals so that they can make...
Breast cancer is among the most common cancers and a major cause of cancer-related death.1 Although the outlook for patients with early breast cancer is good, advanced breast cancer is still...
In the past decade, various targeted therapies have demonstrated improvement in outcomes for patients with advanced renal cell carcinoma (RCC).1 However, most patients on targeted therapy eventually...